OWC Pharmaceutical Research Corp (OWCP)

[EasternTimeZone]

OWC Pharmaceutical to Discuss Cannabis-based Therapies at Monaco Event is HUGE!!

OWC Pharmaceutical to Discuss Cannabis-based Therapies at Monaco Event
APRIL 19, 2017 BY Joana Fernandes, PhD IN NEWS

OWC Pharmaceutical Research will give a presentation in Monaco next week on cannabis-based therapies, which studies have shown help people with fibromyalgia, psoriasis and other inflammatory conditions.

Yehuda Baruch, the company’s chief science officer, will talk about “Cannabis And The Endocannabinoid System: A New And Emerging Pipeline For Medical Products,” at the Monaco Growth Forums Spring Edition, April 25-26.

A key aim is to create interest in cannabis-based therapies in Europe, the company acknowledged.

Cannabis-based treatments have been gaining momentum as a valuable option across a growing range of diseases, including fibromyalgia, psoriasis, multiple myeloma, and migraine headaches. OWC is working on appropriate doses and delivery systems for medical cannabis.

Cannabidiol, the plant’s pure molecular compound, has anti-inflammatory and pain-relieving properties, and no known psycho-active effects. Research has shown that cannabidiol can be an effective treatment for many types of pain, particularly inflammatory pain.

Among those who benefit from cannabis pain relief are fibromyalgia patients, studies have shown. One testament to the treatment was an online survey of more than 1,300 fibromyalgia patients in 2016. Many respondents said cannabis did a better job of treating their symptoms than therapies that the U.S. Food and Drug Administration (FDA) has approved.

A clinical trial has shown that a cannabinoid-based therapy also reduced inflammatory markers in psoriasis. The results suggested it could be used against other inflammation-related disorders.

“We are very excited to participate in this prestigious European event, and looking forward to leverage and share more about OWC Pharmaceutical Research Corp., current active MMJ [medical marijuana] clinical studies with specific overview of our unique topical cream for skin conditions, targeting psoriasis first,” Mordechai Bignitz, the CEO of OWC, said in a news release. “We anticipate that together with some states in the U.S. and Canada, Europe can soon become a primary market for our products.”

Andreea Porcelli, CEO of Monaco Growth Forums, added: “We are proud to include OWC in our conference and especially having Dr. Yehuda Baruch as our Keynote Speaker. Founding and leading the Federal Israeli MMJ program, Dr. Baruch obtained worldwide recognition and is one of the most experienced and knowledgeable physicians in that area.”
https://fibromyalgianewstoday.com/2017/04/19/owc-to-discuss-cannabis-based-therapies-for-fibromyalgia-at-monaco-event/

-------------------------------------------

This Monaco Growth Forums event coming up in less than a week is a really big deal. Dr. Yehuda Baruch, OWCP’s CSO & CTO, will also be a Keynote Speaker at MGF’s Cocktail Reception on Wednesday, April 26th. The keynote topic will be “Cannabis and the Endocannabinoid System: A New and Emerging Pipeline for Medical Products.” https://monacogrowthforums.com/2017/04/owc-pharmaceutical-research-corp-to-present-at-monaco-growth-forums-in-monaco/

MMJ is a very hot emerging market that big investors want to be in and OWCP has been chosen to present their position in this space to 475 institutional investors from over 44 countries, including heads of family offices, fund managers, and private asset managers from major institutions. All attendees at MGF events foster a shared interest in high-growth companies. There will for sure be many institutional investors interested in OWCP. With solid financial backing OWCP can take off and blow expectations away. https://monacogrowthforums.com/about/

Check out the exposure OWCP is getting listed in the Latest News section on the Monaco Growth Forums website. https://monacogrowthforums.com

Looking through the companies presented at the Spring 2016 MGF, the Pot Stock at that conference TRTC saw a huge and sustained bump in it's PPS right after the conference. Still researching this company to see how much it benefited from the MGF conference if at all, but from the chart, it looks like it did by a lot. http://finance.yahoo.com/quote/TRTC?p=TRTC

Also, there will be international media coverage of the conference.